APLS
Apellis Pharmaceuticals Inc Earnings
$20.36
Earnings Summary
Revenue | $212.53Mn |
Net Profits | $-36.35Mn |
Net Profit Margins | -17.11% |
Apellis Pharmaceuticals Inc’s revenue jumped 45.19% since last year same period to $212.53Mn in the Q4 2024. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated 7.98% jump in its revenue since last 3-months.
Apellis Pharmaceuticals Inc’s net profit jumped 58.96% since last year same period to $-36.35Mn in the Q4 2024. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated 36.72% jump in its net profits since last 3-months.
Apellis Pharmaceuticals Inc’s net profit margin jumped 71.73% since last year same period to -17.11% in the Q4 2024. On a quarterly growth basis, Apellis Pharmaceuticals Inc has generated 41.39% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.54 |
EPS Estimate Current Year | -0.54 |
Apellis Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.54 - a -34.36% fall from last quarter’s estimates.
Apellis Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.54.
Key Ratios
Earning Per Share (EPS) | -0.29 |
Apellis Pharmaceuticals Inc’s earning per share (EPS) jumped 60.27% since last year same period to -0.29 in the Q4 2024. This indicates that the Apellis Pharmaceuticals Inc has generated 60.27% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-05 | -0.3 | -0.46 | -54.13% |
2025-02-28 | -0.4 | -0.29 | 27.84% |
2024-08-01 | -0.32 | -0.28 | 12.5% |
2024-05-07 | -0.47 | -0.42 | 10.64% |
